We are pleased to advise that Atenolol-AFT (atenolol 50 mg/10 mL) oral liquid 300 mL is now back in stock in both Australia and New Zealand.
Notice of Adjourned Annual Meeting of Shareholders 2020
Notice is hereby given that the adjourned Annual Meeting of shareholders of AFT Pharmaceuticals Limited (AFT or the Company) will be convened and held on a fully virtual basis on Tuesday, 8 September 2020 commencing at 10.30am (New Zealand time) to transact the business set out in the Notice of Annual Meeting of Shareholders 2020 dated 15 July 2020 (Original AGM Notice).
Retirement of Jon Lamb
Independent director Jon Lamb today retired from the board following his announcement at the ASM.
AFT Pharmaceuticals In-Licenses NovaTears® in Australia and New Zealand
AFT Pharmaceuticals (AFT) has completed a licensing agreement with Novaliq, a German specialty pharmaceutical company, to distribute NovaTears® in Australia and New Zealand.